Australia Makes 'Profoundly Important' Changes To Delivery Of Costly Medicines On PBS
Executive Summary
The Australian government will test a new model next year that will reduce the upfront costs incurred by pharmacies on expensive medicines listed on the Pharmaceutical Benefits Scheme. The changes are expected to free up additional funds to invest in new and earlier PBS listings.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.